Business description
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app.
Management board & Supervisory board
| CEO |
| Christopher Simon |
| Management board |
| James C. D'Arecca, Michelle L. Basil, Kerri DiPietro, Roy Galvin, Jan Hartmann, Anila Lingamneni, Josep Lluis Llorens, Laurie Miller, Stewart W. Strong, Rajeev Varma |
| Supervisory board |
| Ellen M. Zane, Christopher A. Simon, Robert E. Abernathy, Diane M. Bryant, Michael J. Coyle, Charles J. Dockendorff, Lloyd E. Johnson, Mark W. Kroll, Claire Pomeroy |
Company data
| Name: |
Haemonetics Corporation |
| Address: |
125 Summer Street,Boston, MA 02110, USA |
| Phone: |
+1-781-848-7100 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.haemonetics.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
3/31 |
| Free Float: |
99.06% |
| IPO date: |
- |
